A phase I study of doxorubicin in horses with advanced tumors.

被引：0
|
作者：
Theon, A. P. [1 ]
Magdesian, G. K. [1 ]
Pusterla, N. [1 ]
Wilson, W. D. [1 ]
机构：
[1] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA
来源：
JOURNAL OF VETERINARY INTERNAL MEDICINE | 2007年 / 21卷 / 03期
关键词：
D O I：
暂无
中图分类号：
S85 [动物医学（兽医学）];
学科分类号：
0906 ;
摘要：
345
引用
收藏
页码：667 / 667
页数：1
相关论文
共 50 条
  • [21] Phase I study of intravenous (IV) milataxel in adult patients with advanced malignant tumors.
    Bourbouloux, E.
    Campone, M.
    Vermorken, J. B.
    Martin, M.
    Sessa, C.
    Perotti, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 88S - 88S
  • [22] A phase I and pharmacokinetic study of PEG-camptothecin in patients with advanced solid tumors.
    Hao, D
    Tolcher, AW
    Rizzo, JD
    Ochoa, L
    McCreery, H
    Schwartz, GH
    Patnaik, A
    Denis, LJ
    Hammond, LA
    Hidalgo, M
    Kwiatek, J
    McGuire, J
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 2000, 6 : 4513S - 4513S
  • [23] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Papadopoulos, Kyriakos P.
    Adewoye, Adeboye H.
    Hunter, John
    Ramsey, Denise
    ElNaggar, Adam
    Patnaik, Amita
    Vaena, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [24] Phase I study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.
    Xu, B.
    Shen, L.
    Ye, D.
    Jappe, A.
    Wang, H.
    Yuan, R.
    Wu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [26] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Vaena, Daniel A.
    Sullivan, Ryan J.
    Luke, Jason J.
    ElNaggar, Adam
    Hunter, John
    Adewoye, Adeboye H.
    Olweny, Judy
    Patnaik, Amita
    Hamilton, Erika Paige
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors.
    Dudek, A
    Larson, T
    Mellskog, CE
    Bloss, LP
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 162S - 162S
  • [28] Phase I study of weekly docetaxel and liposomal doxorubicin in patients with advanced solid tumors
    Kouroussis, C
    Androulakis, N
    Vamvakas, L
    Kalykaki, A
    Spiridonakou, S
    Kentepozidis, N
    Saridaki, Z
    Xiropoulou, E
    Georgoulias, V
    ONCOLOGY, 2005, 69 (03) : 202 - 207
  • [29] A phase I study of metformin and chemotherapy in solid tumors.
    Kritharis, Athena
    Caplain, Jennifer
    Rajagopal, Shrikar
    Grimm, Elizabeth
    Tsichlis, Philip N.
    Martell, Robert
    Saif, Waslf M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [30] Phase I and pharmacokinetic study of farletuzumab in solid tumors.
    Sasaki, Yasutsuna
    Miwa, Keisuke
    Yamashita, Keishi
    Fujiwara, Keiichi
    Katsumata, Noriyuki
    Fujiwara, Yasuhiro
    Namiki, Masayuki
    Koyanagi, Nozomu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345